TELA Bio director granted new equity awards
TELA Bio director Paul Thomas reported new equity awards.
Rhea-AI Filing Summary
TELA Bio director Paul Thomas reported new equity awards. On June 9, 2026, he received two grants of Common Stock: 11,675 restricted stock units that vest in three equal annual installments starting June 9, 2027, and 11,925 restricted stock units that vest by the earlier of June 9, 2027, the next annual stockholder meeting, or a Change in Control, in each case subject to continued service.
He also received stock options for 17,335 and 17,550 shares of Common Stock at an exercise price of $0.935 per share, expiring on June 9, 2036. One option grant vests in 36 equal monthly installments beginning on June 9, 2026, and the other vests on the earlier of June 9, 2027, the next annual meeting, or a Change in Control, subject to continued service.
Positive
- None.
Negative
- None.
Insider Trade Summary
Grant/Award: 58,485 shares
Grant/Award
4 txns
Insider
THOMAS PAUL
Role
Director
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Grant/Award | Stock Option (Right to Buy) | 17,550 | $0.00 | $0.00 |
| Grant/Award | Stock Option (Right to Buy) | 17,335 | $0.00 | $0.00 |
| Grant/Award | Common Stock | 11,925 | $0.00 | $0.00 |
| Grant/Award | Common Stock | 11,675 | $0.00 | $0.00 |
Holdings After Transaction:
Stock Option (Right to Buy) — 34,885 contracts (Direct);
Common Stock — 23,600 shares (Direct)
Footnotes (4)
- F1. These restricted stock units will vest in three equal annual installments beginning on June 9, 2027, in each case subject to the Reporting Person's continued service through the applicable vesting date.
- F2. These restricted stock units vest on the earlier of (a) June 9, 2027, (b) the next annual meeting of stockholders, or (c) the occurrence of a Change in Control (as defined in the Issuer's Amended and Restated 2019 Equity Incentive Plan), in each case subject to the Reporting Person's continued service through the applicable vesting date.
- F3. The option vests in 36 equal monthly installments on each monthly anniversary of June 9, 2026, in each case subject to the Reporting Person's continued service through the applicable vesting date.
- F4. The option vests on the earlier of (a) June 9, 2027, (b) the next annual meeting of stockholders, or (c) the occurrence of a Change in Control (as defined in the Issuer's Amended and Restated 2019 Equity Incentive Plan), in each case subject to the Reporting Person's continued service through the applicable vesting date.
Key Figures
RSU grant 1: 11,675 shares of Common Stock
RSU grant 2: 11,925 shares of Common Stock
Option grant 1 size: 17,335 options
+5 more
8 metrics
RSU grant 1
11,675 shares of Common Stock
Restricted stock units vesting in three equal annual installments from June 9, 2027
RSU grant 2
11,925 shares of Common Stock
Restricted stock units vesting by earlier of June 9, 2027, next annual meeting, or Change in Control
Option grant 1 size
17,335 options
Stock options over Common Stock at $0.935 exercise price
Option grant 2 size
17,550 options
Stock options over Common Stock at $0.935 exercise price
Option strike price
$0.935 per share
Exercise price for both new stock option grants
Option expiration
June 9, 2036
Expiration date for both stock option grants
Shares held after first RSU grant
23,600 shares
Total Common Stock following the 11,675-share award
Shares held after second RSU grant
11,925 shares
Total Common Stock related to the 11,925-share award
Key Terms
restricted stock units, Change in Control, Amended and Restated 2019 Equity Incentive Plan, stock option, +1 more
5 terms
restricted stock units financial
"These restricted stock units will vest in three equal annual installments..."
Restricted stock units are a type of company reward where employees are promised shares of stock, but they only fully own these shares after meeting certain conditions, like staying with the company for a set time. They matter because they can become valuable assets and are often used to motivate employees to help the company succeed.
Change in Control financial
"the occurrence of a Change in Control (as defined in the Issuer's Amended..."
A "change in control" occurs when the ownership or management of a company shifts significantly, such as through a merger, acquisition, or sale of a large part of its assets. This change can impact how the company is run and may influence its future direction. For investors, it matters because it can affect the company's stability, strategy, and value, often signaling potential changes in investment risk or opportunity.
Amended and Restated 2019 Equity Incentive Plan financial
"as defined in the Issuer's Amended and Restated 2019 Equity Incentive Plan..."
stock option financial
"The option vests in 36 equal monthly installments on each monthly anniversary..."
A stock option is a contract that gives you the right to buy or sell a company's stock at a specific price within a certain time frame. People use them to potentially make money if the stock's price moves favorably or to protect against losses. It's like holding a coupon that can be used to buy or sell stock at a set price later on.
vesting financial
"in each case subject to the Reporting Person's continued service through the applicable vesting date."
Vesting is the process by which you earn full ownership of something, like company stock or a retirement benefit, over time. It’s like earning the right to keep a gift piece by piece the longer you stay with a company, making sure employees stay committed before they receive all the benefits.
FAQ
What equity awards did TELA (TELA) director Paul Thomas receive?
Paul Thomas received two restricted stock unit grants and two stock option grants in TELA Bio Common Stock. The RSUs cover 11,675 and 11,925 shares, while the options cover 17,335 and 17,550 shares at a strike price of $0.935 per share.
How do Paul Thomas’s new RSU awards at TELA (TELA) vest?
One RSU award of 11,675 shares vests in three equal annual installments starting June 9, 2027. The 11,925-share RSU award vests by the earlier of June 9, 2027, the next annual stockholder meeting, or a Change in Control, subject to continued service.
What are the terms of Paul Thomas’s new TELA (TELA) stock options?
Thomas received stock options over 17,335 and 17,550 TELA Bio shares at an exercise price of $0.935 per share. Both option grants expire on June 9, 2036, with one vesting monthly over 36 months and the other vesting on specified earlier events.
Are Paul Thomas’s TELA (TELA) Form 4 transactions open-market purchases?
No, the Form 4 transactions reflect equity awards, not open-market purchases. All four entries are coded as grants or awards, with a per-share transaction price of $0.0000, indicating compensation-related grants rather than discretionary buying in the public market.
What service conditions apply to Paul Thomas’s new TELA (TELA) awards?
All RSU and option awards require Paul Thomas’s continued service through each vesting date. Some vest over time in installments, while others vest on the earlier of June 9, 2027, the next annual meeting, or a qualifying Change in Control event.
AI-generated analysis. How Rhea-AI works. Not financial advice.
